Krsnaa Diagnost.

Market Cap: Small Cap
Industry: Healthcare Services
ISIN: INE08LI01020
NSEID: KRSNAA
BSEID: 543328

INR

735.70

-0.55 (-0.07%)

BSENSE

Dec 12

BSE+NSE Vol: 43.88 k

{
  "main_header": {
    "sid": 1003520,
    "name": "Krsnaa Diagnost.",
    "stock_name": "Krsnaa Diagnost.",
    "full_name": "Krsnaa Diagnostics Ltd",
    "name_url": "stocks-analysis/krsnaa-diagnost",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "735.70",
    "chg": -0.55,
    "chgp": "-0.07%",
    "dir": -1,
    "prev_price": "736.25",
    "mcapval": "2,402.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543328,
    "symbol": "KRSNAA",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE08LI01020",
    "curr_date": "Dec 12",
    "curr_time": "",
    "bse_nse_vol": "43.88 k",
    "exc_status": "Active",
    "traded_date": "Dec 12, 2025",
    "traded_date_str": "2025 12 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/krsnaa-diagnost-1003520-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Krsnaa Diagnostics Valuation Shift Highlights Price Attractiveness Amid Sector Comparison",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/krsnaa-diagnostics-valuation-shifts-signal-renewed-price-attractiveness-amid-market-challenges-3752625",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KrsnaaDiagnosti_valuationdot_3752625.png",
        "date": "2025-12-09 08:00:53",
        "description": "Krsnaa Diagnostics has experienced a notable revision in its valuation parameters, reflecting a shift in market assessment that positions the stock as very attractive relative to its historical averages and peer group within the healthcare services sector. This article analyses the recent changes in key financial metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios, alongside enterprise value multiples, to provide a comprehensive view of the stock’s current price attractiveness."
      },
      {
        "title": "Is Krsnaa Diagnost. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-krsnaa-diagnost-technically-bullish-or-bearish-3745665",
        "imagepath": "",
        "date": "2025-12-04 08:45:41",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Overview of Technical Indicators</strong></p>\n<p>The latest technical data as of 03 Dec 2025 reveals a nuanced picture for Krsnaa Diagnost. The overall trend has transitioned from sideways to mildly bearish, indicating a subtle but notable shift in market momentum. Key momentum indicators such as the Moving Average Convergence Divergence (MACD) on both weekly and monthly charts are mildly bearish, signalling that downward pressure may be building.</p>\n<p>Similarly, the Bollinger Bands on weekly and monthly timeframes are bearish, suggesting that the stock price is trading near the lower band, which often reflects increased volatility and potential downside risk. The Know Sure Thing (KST) indicator, which helps identify major price cycles, also aligns with a mildly bearish outlook on weekly a..."
      },
      {
        "title": "Krsnaa Diagnostics Technical Momentum Shifts Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/krsnaa-diagnostics-faces-mildly-bearish-technical-shift-amid-market-underperformance-3745540",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KrsnaaDiagnosti_technicaldot_3745540.png",
        "date": "2025-12-04 08:12:25",
        "description": "Krsnaa Diagnostics has experienced a notable shift in its technical momentum, reflecting evolving market dynamics within the healthcare services sector. Recent assessment changes reveal a transition from a sideways trend to a mildly bearish stance, with key technical indicators signalling nuanced movements in price momentum and investor sentiment."
      },
      {
        "title": "Krsnaa Diagnostics: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/krsnaa-diagnostics-downgraded-to-sell-amid-technical-and-financial-concerns-3743163",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KrsnaaDiagnosti_mojoScore_3743163.png",
        "date": "2025-12-03 08:27:45",
        "description": "Krsnaa Diagnostics has experienced a revision in its market assessment following a detailed evaluation of its quality, valuation, financial trends, and technical indicators. The healthcare services company’s recent performance and market behaviour have prompted a nuanced reassessment, reflecting a complex interplay of factors that investors should carefully consider."
      },
      {
        "title": "Krsnaa Diagnostics Faces Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/krsnaa-diagnostics-faces-technical-momentum-shift-amid-bearish-signals-3743042",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KrsnaaDiagnosti_technicaldot_3743042.png",
        "date": "2025-12-03 08:08:58",
        "description": "Krsnaa Diagnostics has experienced a notable shift in its technical landscape, with recent evaluation adjustments reflecting a transition from a mildly bullish trend to a sideways momentum. The stock’s price action, combined with key technical indicators such as MACD, RSI, and moving averages, presents a complex picture for investors navigating the healthcare services sector."
      },
      {
        "title": "How has been the historical performance of Krsnaa Diagnost.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-krsnaa-diagnost-3742282",
        "imagepath": "",
        "date": "2025-12-02 23:06:26",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Growth</strong></p>\n<p>Over the four-year period, Krsnaa Diagnost. has seen its net sales increase steadily from ₹455.45 crores in March 2022 to ₹717.16 crores in March 2025. This represents a compound growth trend reflecting the company’s expanding market presence and operational scale. Total operating income mirrored this growth, with no other operating income reported, indicating that core business activities have been the primary revenue drivers.</p>\n<p>Operating profit before depreciation and interest (PBDIT excluding other income) rose from ₹131.48 crores in March 2022 to ₹190.12 crores in March 2025, signalling improved operational efficiency. Including other income, operating profit (PBDIT) increased from ₹146.39 crores to ₹215.66 crores over the same period. Howev..."
      },
      {
        "title": "Is Krsnaa Diagnost. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-krsnaa-diagnost-overvalued-or-undervalued-3709961",
        "imagepath": "",
        "date": "2025-11-18 08:25:37",
        "description": "As of 17 November 2025, Krsnaa Diagnostics has moved from a very attractive to an attractive valuation grade. The company is currently considered fairly valued. Key ratios include a PE ratio of 31.76, an EV to EBITDA of 13.62, and a PEG ratio of 1.47. \n\nIn comparison to peers, Krsnaa Diagnostics has a lower PE ratio than Apollo Hospitals, which stands at 64.41, indicating that Krsnaa may be more reasonably priced despite its attractive valuation. Other peers like Max Healthcare and Fortis Healthcare are significantly more expensive, with PE ratios of 77.22 and 70.78, respectively. Although Krsnaa Diagnostics has underperformed the Sensex year-to-date, it has shown strong returns over the past three years, outperforming the index with a return of 79.08%...."
      },
      {
        "title": "Krsnaa Diagnostics Adjusts Valuation Amid Strong Performance in Healthcare Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/krsnaa-diagnostics-valuation-grade-downgraded-from-very-attractive-to-attractive-3710090",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KrsnaaDiagnosti_valuationdot_3710090.png",
        "date": "2025-11-18 08:03:42",
        "description": "Krsnaa Diagnostics, a small-cap healthcare services company, has recently adjusted its valuation, with its stock price rising to 828.05. The company has outperformed the Sensex over the past week, showcasing strong financial metrics, including a PE ratio of 31.76 and a favorable position compared to industry competitors."
      },
      {
        "title": "Krsnaa Diagnostics Reports Flat Financial Performance Amid Mixed Operational Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/krsnaa-diagnostics-stock-rating-adjusted-to-hold-amid-flat-financial-results-3696710",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KrsnaaDiagnosti_mojoScore_3696710.png",
        "date": "2025-11-13 08:26:04",
        "description": "Krsnaa Diagnostics has recently adjusted its evaluation based on its financial performance for the quarter ending September 2025, reporting flat results. The company achieved record operating cash flow and net sales, while also facing challenges in certain financial metrics. Institutional investor participation has increased, reflecting a favorable valuation profile."
      }
    ],
    "total": 257,
    "sid": "1003520",
    "stock_news_url": "https://www.marketsmojo.com/news/krsnaa-diagnostics-1003520"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Krsnaa Diagnostics Ltd has declared <strong>55%</strong> dividend, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Krsnaa Diagnostics Valuation Shift Highlights Price Attractiveness Amid Sector Comparison

2025-12-09 08:00:53

Krsnaa Diagnostics has experienced a notable revision in its valuation parameters, reflecting a shift in market assessment that positions the stock as very attractive relative to its historical averages and peer group within the healthcare services sector. This article analyses the recent changes in key financial metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios, alongside enterprise value multiples, to provide a comprehensive view of the stock’s current price attractiveness.

Is Krsnaa Diagnost. technically bullish or bearish?

2025-12-04 08:45:41

Overview of Technical Indicators

The latest technical data as of 03 Dec 2025 reveals a nuanced picture for Krsnaa Diagnost. The overall trend has transitioned from sideways to mildly bearish, indicating a subtle but notable shift in market momentum. Key momentum indicators such as the Moving Average Convergence Divergence (MACD) on both weekly and monthly charts are mildly bearish, signalling that downward pressure may be building.

Similarly, the Bollinger Bands on weekly and monthly timeframes are bearish, suggesting that the stock price is trading near the lower band, which often reflects increased volatility and potential downside risk. The Know Sure Thing (KST) indicator, which helps identify major price cycles, also aligns with a mildly bearish outlook on weekly a...

Krsnaa Diagnostics Technical Momentum Shifts Amid Market Volatility

2025-12-04 08:12:25

Krsnaa Diagnostics has experienced a notable shift in its technical momentum, reflecting evolving market dynamics within the healthcare services sector. Recent assessment changes reveal a transition from a sideways trend to a mildly bearish stance, with key technical indicators signalling nuanced movements in price momentum and investor sentiment.

Krsnaa Diagnostics: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals

2025-12-03 08:27:45

Krsnaa Diagnostics has experienced a revision in its market assessment following a detailed evaluation of its quality, valuation, financial trends, and technical indicators. The healthcare services company’s recent performance and market behaviour have prompted a nuanced reassessment, reflecting a complex interplay of factors that investors should carefully consider.

Krsnaa Diagnostics Faces Mixed Technical Signals Amid Price Momentum Shift

2025-12-03 08:08:58

Krsnaa Diagnostics has experienced a notable shift in its technical landscape, with recent evaluation adjustments reflecting a transition from a mildly bullish trend to a sideways momentum. The stock’s price action, combined with key technical indicators such as MACD, RSI, and moving averages, presents a complex picture for investors navigating the healthcare services sector.

How has been the historical performance of Krsnaa Diagnost.?

2025-12-02 23:06:26

Revenue and Profit Growth

Over the four-year period, Krsnaa Diagnost. has seen its net sales increase steadily from ₹455.45 crores in March 2022 to ₹717.16 crores in March 2025. This represents a compound growth trend reflecting the company’s expanding market presence and operational scale. Total operating income mirrored this growth, with no other operating income reported, indicating that core business activities have been the primary revenue drivers.

Operating profit before depreciation and interest (PBDIT excluding other income) rose from ₹131.48 crores in March 2022 to ₹190.12 crores in March 2025, signalling improved operational efficiency. Including other income, operating profit (PBDIT) increased from ₹146.39 crores to ₹215.66 crores over the same period. Howev...

Is Krsnaa Diagnost. overvalued or undervalued?

2025-11-18 08:25:37

As of 17 November 2025, Krsnaa Diagnostics has moved from a very attractive to an attractive valuation grade. The company is currently considered fairly valued. Key ratios include a PE ratio of 31.76, an EV to EBITDA of 13.62, and a PEG ratio of 1.47. In comparison to peers, Krsnaa Diagnostics has a lower PE ratio than Apollo Hospitals, which stands at 64.41, indicating that Krsnaa may be more reasonably priced despite its attractive valuation. Other peers like Max Healthcare and Fortis Healthcare are significantly more expensive, with PE ratios of 77.22 and 70.78, respectively. Although Krsnaa Diagnostics has underperformed the Sensex year-to-date, it has shown strong returns over the past three years, outperforming the index with a return of 79.08%....

Krsnaa Diagnostics Adjusts Valuation Amid Strong Performance in Healthcare Sector

2025-11-18 08:03:42

Krsnaa Diagnostics, a small-cap healthcare services company, has recently adjusted its valuation, with its stock price rising to 828.05. The company has outperformed the Sensex over the past week, showcasing strong financial metrics, including a PE ratio of 31.76 and a favorable position compared to industry competitors.

Krsnaa Diagnostics Reports Flat Financial Performance Amid Mixed Operational Metrics

2025-11-13 08:26:04

Krsnaa Diagnostics has recently adjusted its evaluation based on its financial performance for the quarter ending September 2025, reporting flat results. The company achieved record operating cash flow and net sales, while also facing challenges in certain financial metrics. Institutional investor participation has increased, reflecting a favorable valuation profile.